GLP-1 medications like semaglutide work by slowing stomach emptying and signaling satiety to your brain, typically producing measurable weight loss within 4 to 8 weeks of consistent use
Liver diseases, including cirrhosis and hepatitis, and kidney diseases like chronic kidney disease and nephrotic syndrome, may also be managed with this formulation
With manufacturing of approved products now keeping up with demand, the prior justification for compounded GLP-1s has largely disappeared
Regarding mortality and cancer outcomes, dietary selenium intake at the highest dose could decrease the risk of all-cause mortality in adults compared to the lowest dose
+ - 5-Amino-1MQ and NAD+ work synergistically to boost cellular energy, with 5-Amino-1MQ acting as a metabolic "mechanic" that inhibits the NNMT enzyme to prevent waste, while NAD+ acts as the fuel
This allows for deep tissue penetration, immune modulation, and whole-body collagen remodeling